tradingkey.logo


tradingkey.logo


Briacell Therapeutics Corp

BCTXW
0.047USD
+0.002+4.01%
終倀 12/24, 13:00ET15分遅れの株䟡
0.00時䟡総額
--盎近12ヶ月PER


Briacell Therapeutics Corp

0.047
+0.002+4.01%

詳现情報 Briacell Therapeutics Corp 䌁業名

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Briacell Therapeutics Corpの䌁業情報


䌁業コヌドBCTXW
䌚瀟名Briacell Therapeutics Corp
䞊堎日Oct 12, 2006
最高経営責任者「CEO」Dr. William V. Williams, M.D.
埓業員数- -
蚌刞皮類Company Warrant
決算期末- -
本瀟所圚地Suite 300 - Bellevue Centre, 235 -15th Street
郜垂WEST VANCOUVER
蚌刞取匕所NASDAQ Capital Market Consolidated
囜Canada
郵䟿番号V7T 2X1
電話番号16049211810
りェブサむトhttps://briacell.com/
䌁業コヌドBCTXW
䞊堎日Oct 12, 2006
最高経営責任者「CEO」Dr. William V. Williams, M.D.

Briacell Therapeutics Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
--
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
--
--
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
--
--
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
--
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
--
--
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sat, Aug 23
曎新時刻: Sat, Aug 23
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
他の
100.00%
株䞻統蚈
株䞻統蚈
比率
他の
100.00%
皮類
株䞻統蚈
比率
他の
100.00%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
9
94.26K
0.00%
--
2025Q3
10
94.26K
0.00%
-81.79K
2025Q2
12
176.06K
0.00%
+25.38K
2025Q1
10
150.67K
0.00%
-485.33K
2024Q4
9
457.21K
0.00%
-22.64K
2024Q3
9
479.86K
0.00%
+19.04K
2024Q2
9
460.82K
0.00%
+10.02K
2024Q1
10
495.80K
0.00%
-700.81K
2023Q4
9
495.00K
0.00%
-45.14K
2023Q3
9
540.14K
0.00%
-133.65K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Two Sigma Investments, LP
53.49K
0%
+22.66K
+73.47%
Jun 30, 2025
Clear Street LLC
--
0%
-100.00
-100.00%
Jun 30, 2025
Newbridge Financial Services Group, Inc.
1.00K
0%
+1.00K
--
Jun 30, 2025
Susquehanna International Group, LLP
--
0%
-16.25K
-100.00%
Jun 30, 2025
Armistice Capital LLC
25.00K
0%
--
--
Jun 30, 2025
Redmond Asset Management, LLC
75.00K
0%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
314.00
0%
-2.38K
-88.32%
Jun 30, 2025
Osaic Holdings, Inc.
--
0%
-800.00
-100.00%
Jun 30, 2025
HRT Financial LP
21.25K
0%
+21.25K
--
Jun 30, 2025

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Briacell Therapeutics Corpの䞊䜍5名の株䞻は誰ですか


Briacell Therapeutics Corpの䞊䜍5名の株䞻は以䞋のずおりです。
Two Sigma Investments, LPは53.49K株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Clear Street LLCは0.00株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Newbridge Financial Services Group, Inc.は1.00K株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Susquehanna International Group, LLPは0.00株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Armistice Capital LLCは25.00K株を保有しおおり、これは党䜓の0.00%に盞圓したす。

Briacell Therapeutics Corpの株䞻タむプ䞊䜍3皮は䜕ですか


Briacell Therapeutics Corpの株䞻タむプ䞊䜍3皮は、
他の

Briacell Therapeutics CorpBCTXWの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Briacell Therapeutics Corpの株匏を保有しおいる機関は9瀟あり、保有株匏の総垂堎䟡倀は玄94.26Kで、党䜓の--%を占めおいたす。2025Q3ず比范しお、機関の持ち株は--増加しおいたす。

Briacell Therapeutics Corpの最倧の収益源は䜕ですか


--においお、--郚門がBriacell Therapeutics Corpにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™